User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary

作者
Karina Karolina De Santis,Dawid Pieper,Robert C. Lorenz,Uta E Wegewitz,Waldemar Siemens,Katja Matthias
出处
期刊:BMC Medical Research Methodology [BioMed Central]
卷期号:23 (1): 63-63 被引量:38
标识
DOI:10.1186/s12874-023-01879-8
摘要

BACKGROUND: 'A Measurement Tool to Assess Systematic Reviews, version 2' (AMSTAR 2) is a validated 16-item scale designed to appraise systematic reviews (SRs) of healthcare interventions and to rate the overall confidence in their results. This commentary aims to describe the challenges with rating of the individual items and the application of AMSTAR 2 from the user perspective. DISCUSSION: A group of six experienced users (methodologists working in different clinical fields for at least 10 years) identified and discussed the challenges in rating of each item and the general use of AMSTAR 2 to appraise SRs. A group discussion was used to develop recommendations on how users could deal with the identified challenges. We identified various challenges with the content of items 2-16 and with the derivation of the overall confidence ratings on AMSTAR 2. These challenges include the need (1) to provide additional definitions (e.g., what constitutes major deviations from SR protocol on item 2), (2) to choose a rating strategy for multiple conditions on single items (e.g., how to rate item 5 if studies were selected in duplicate, but consensus between two authors was not reported), and (3) to determine rules for deriving the confidence ratings (e.g., what items are critical for such ratings). Based on these challenges we formulated specific recommendations for items 2-16 that AMSTAR 2 users could consider before applying the tool. Our commentary adds to the existing literature by providing the first in-depth examination of the AMSTAR 2 tool from the user perspective. The identified challenges could be addressed by additional decision rules including definitions for ambiguous items and guidance for rating of complex items and derivation of confidence ratings. We recommend that a team consensus regarding such decision rules is required before appraisal procedure begins. TRIAL REGISTRATION: Not applicable.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
younger发布了新的文献求助10
刚刚
做猪要开心完成签到,获得积分10
1秒前
1秒前
Carrie发布了新的文献求助10
1秒前
FashionBoy的应助被馒头就辣条采纳,获得10
2秒前
liu关闭了liu的文献求助
2秒前
一叶完成签到 ,获得积分10
3秒前
3秒前
打打的应助被晚风采纳,获得10
3秒前
华仔的应助被爱听歌的寄云采纳,获得10
4秒前
4秒前
4秒前
4秒前
5秒前
qin202569发布了新的文献求助10
5秒前
不穷知识发布了新的文献求助10
5秒前
Crssss的应助被younger采纳,获得10
6秒前
情怀的应助被younger采纳,获得10
6秒前
7秒前
机智小馒头完成签到,获得积分10
8秒前
8秒前
8秒前
落骛发布了新的文献求助10
8秒前
9秒前
buta完成签到,获得积分10
9秒前
大爱人生完成签到 ,获得积分10
9秒前
9秒前
dy发布了新的文献求助10
10秒前
12秒前
pykw的应助被科研通管家采纳,获得10
12秒前
研友_VZG7GZ的应助被罗伯特骚塞采纳,获得10
12秒前
SciGPT的应助被飘逸衣采纳,获得30
12秒前
FashionBoy的应助被科研通管家采纳,获得10
12秒前
wwwww发布了新的文献求助30
12秒前
隐形曼青的应助被科研通管家采纳,获得10
12秒前
Hello的应助被科研通管家采纳,获得10
12秒前
英姑的应助被酷炫的傲芙采纳,获得10
12秒前
orixero的应助被科研通管家采纳,获得10
12秒前
13秒前
李爱国的应助被cwm采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593